Biofrontera has named Gerard DiGirolamo as national sales director. In the newly created role, DiGirolamo will oversee the planned launch of BF-RhodoLED XL as well as efforts to support Ameluz, BF-RhodoLED and Xepi.

DiGirolamo has more than two decades of experience, including most recently as VP of Sales at Verrica Pharmaceuticals. He also previously worked at GSK, Stiefel and Novartis.

“Gerard’s insight and understanding of the dermatology market, along with the many relationships he’s cultivated within our industry will be extremely valuable in working with Mark Baldyga on the successful implementation of our commercial strategy,” Biofrontera CEO Erica Monaco said in a statement.